Item 2.02 Results of Operations and Financial Condition.

On August 5, 2021, Vir Biotechnology, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2021. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information in this Item 2.02, including the attached Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits
Exhibit No.     Description
99.1              Press Release of the Company, dated August 5, 2021
104             Cover Page Interactive Data File (embedded within the Inline
                XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses